NorthWest Biotherapeutics Inc (NWBO)

[Hopeforthefuture3]

HR2, I'm confused by your second graph. The first one mgmt methylated matches the presented slide deck except for the addition of the blue line (I find that interesting).
The second graph labeled minimal residual disease does not remotely match the slide that I have from the presentation. Your slide shows at the median 16.5 vs 19.3 months advantage to dcvax and p value of 0.002 hr of 0.80 (not looking at the blue line)
If I look at the presentation slide on nGBM for minimal residual disease I see at the median months of survival at 20.3 vs 20.4 months, p value of 0.524 and hazard ratio of 1.01. Vastly different, what am I missing or do I have the wrong slide? Your slide on minimal residual disease is showing very favorable impact from dcvax, the one I'm looking at shows no impact (all just at the median)
Can you explain or am I just looking at it wrong?